STOCK-BASED COMPENSATION - (Tables)
|
3 Months Ended |
Jun. 30, 2026 |
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Stock-based Compensation Activity, by Award Type |
The Company's stock-based compensation activity for the three months ended June 30, 2026 and 2025, by award type, was (dollars in thousands): | | | | | | | | | | | | | | | | | For the three months ended | | | June 30, | | | 2026 | | 2025 | | Stock options | | $ | 299 | | | $ | 705 | | | | | | | | Restricted stock units, time-vesting | | 13,197 | | | 17,817 | | | Restricted stock units, performance-based | | 6,260 | | | 4,933 | | | | | | | | Habu restricted stock awards | | 4 | | | 25 | | | | | | | | | | | | | | | | | | | | | | | | | | | | Habu acquisition consideration holdback | | 689 | | | 1,219 | | | Employee stock purchase plan | | 235 | | | 398 | | | Directors stock-based compensation | | 258 | | | 313 | | | Total non-cash stock-based compensation included in the condensed consolidated statements of operations | | 20,942 | | | 25,410 | | | Less expense related to liability-based equity awards | | (689) | | | (1,210) | | | | | | | | Total non-cash stock-based compensation included in the condensed consolidated statements of equity | | $ | 20,253 | | | $ | 24,200 | |
|
| Schedule of Effect of Stock-based Compensation Expense on Income, by Financial Statement Line Item |
The effect of stock-based compensation expense on operations, by financial statement line item, was (dollars in thousands): | | | | | | | | | | | | | | | | | For the three months ended | | | June 30, | | | 2026 | | 2025 | | Cost of revenue | | $ | 1,097 | | | $ | 1,541 | | | Research and development | | 5,829 | | | 8,332 | | | Sales and marketing | | 3,975 | | | 6,014 | | | General and administrative | | 10,041 | | | 9,523 | | | Total non-cash stock-based compensation included in the condensed consolidated statements of operations | | $ | 20,942 | | | $ | 25,410 | |
|
| Schedule of Share-based Compensation Arrangement by Share Based Payment Award, Future Expense |
The following table provides the expected future expense for all of the Company's outstanding equity awards at June 30, 2026, by award type. The amount for fiscal 2027 represents the remaining nine months ending March 31, 2027. All other periods represent fiscal years ending March 31 (dollars in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | For the years ending March 31, | | | 2027 | | 2028 | | 2029 | | 2030 | | | | Total | | Stock options | | $ | 640 | | | $ | 95 | | | $ | — | | | $ | — | | | | | $ | 735 | | | Restricted stock units | | 53,175 | | | 49,145 | | | 24,955 | | | 2,276 | | | | | 129,551 | | | | | | | | | | | | | | | | Habu acquisition consideration holdback | | 1,607 | | | — | | | — | | | — | | | | | 1,607 | | | | | | | | | | | | | | | | Expected future expense | | $ | 55,422 | | | $ | 49,240 | | | $ | 24,955 | | | $ | 2,276 | | | | | $ | 131,893 | |
|
| Schedule of Option Activity |
Stock options activity for the three months ended June 30, 2026 was: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Weighted-average | | | | | | | Weighted-average | | remaining | | Aggregate | | | Number of | | exercise price | | contractual term | | Intrinsic value | | | shares | | per share | | (in years) | | (in thousands) | | Outstanding at March 31, 2026 | | 90,610 | | | $ | 9.69 | | | | | | | | | | | | | | | | Exercised | | (20,317) | | | $ | 10.03 | | | | | $ | 556 | | | Forfeited or canceled | | (3,736) | | | $ | 12.67 | | | | | | | Outstanding at June 30, 2026 | | 66,557 | | | $ | 9.42 | | | 6.4 | | $ | 1,878 | | | Exercisable at June 30, 2026 | | 41,384 | | | $ | 9.31 | | | 6.2 | | $ | 1,172 | |
|
| Schedule of Stock Options Outstanding and Exercisable |
A summary of stock options outstanding and exercisable as of June 30, 2026 was: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Options outstanding | | Options exercisable | | Range of | | | | Weighted-average | | Weighted-average | | | | Weighted-average | | exercise price | | Options | | remaining | | exercise price | | Options | | exercise price | | per share | | outstanding | | contractual life | | per share | | exercisable | | per share | | $ | 1.20 | | | — | | $ | 9.99 | | | 66,557 | | | 6.4 years | | $ | 9.42 | | | 41,384 | | | $ | 9.31 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 66,557 | | | 6.4 years | | $ | 9.42 | | | 41,384 | | | $ | 9.31 | |
|
| Schedule of Changes in Restricted Stock |
Habu restricted stock share activity for the three months ended June 30, 2026 was:
| | | | | | | | | | | | | | | | | | | | | | | | | Weighted average | | | | | | | fair value per | | Weighted average | | | Number | | share at grant | | remaining contractual | | | of shares | | date | | term (in years) | | Unvested restricted stock awards at March 31, 2026 | | 160 | | | $ | 39.48 | | | 0.3 | | | | | | | | | Vested | | (106) | | | $ | 39.48 | | | | | Forfeited or canceled | | (54) | | | $ | 39.48 | | | | | Unvested restricted stock awards at June 30, 2026 | | — | | | $ | — | | | 0.0 |
|
| Schedule of Time-vesting Restricted Stock Unit Activity |
RSU activity for the three months ended June 30, 2026 was: | | | | | | | | | | | | | | | | | | | | | | | | | Weighted-average | | | | | | | fair value per | | Weighted-average | | | Number | | share at grant | | remaining contractual | | | of shares | | date | | term (in years) | | Outstanding at March 31, 2026 | | 2,921,142 | | | $ | 30.36 | | | 1.89 | | Granted | | 1,306,908 | | | $ | 37.77 | | | | | Vested | | (768,308) | | | $ | 30.33 | | | | | | | | | | | | Forfeited or canceled | | (144,008) | | | $ | 32.47 | | | | | Outstanding at June 30, 2026 | | 3,315,734 | | | $ | 33.20 | | | 2.15 |
|
| Schedule of Non-vested Performance-based Restricted Stock Units Activity |
PSU activity for the three months ended June 30, 2026 was: | | | | | | | | | | | | | | | | | | | | | | | | | Weighted-average | | | | | | | fair value per | | Weighted-average | | | Number | | share at grant | | remaining contractual | | | of shares | | date | | term (in years) | | Outstanding at March 31, 2026 | | 1,445,075 | | | $ | 33.43 | | | 1.06 | | Granted | | 345,123 | | | $ | 44.28 | | | | | | | | | | | | Vested | | (432,580) | | | $ | 29.56 | | | | | | | | | | | | Forfeited or canceled | | (57,178) | | | $ | 35.28 | | | | | Outstanding at June 30, 2026 | | 1,300,440 | | | $ | 37.51 | | | 1.64 |
|